Synchronous carotid body and thoracic paraganglioma associated with a germline SDHC mutation  by Vandy, Frank C. et al.
Synchronous carotid body and thoracic
paraganglioma associated with a germline
SDHC mutation
Frank C. Vandy, MD, Geoffroy Sisk, MD, and Ramon Berguer, MD, Ann Arbor, Mich
Paraganglionic tumors are rare. A germline mutation responsible for a familial pattern of paragangliomas (PGLs) has
been identified on the genes encoding for the subunits of succinate dehydrogenase (SDH). Manifestations of those with
a succinate dehydrogenase subunit C (SDHC) germlinemutation have been almost exclusively reported as single head and
neck paragangliomas (HNPGLs). We present a 32-year-old man with a familial SDHC mutation who manifests
synchronous PGLs of the carotid body and the thoracic aortopulmonary window. To our knowledge, this is the first
report of such a presentation for this mutation. (J Vasc Surg 2011;53:805-7.)
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tTumors originating from the paraganglionic system are
rare. The majority of such tumors are pheochromocy-
tomas (PCs) with intra-abdominal location, secrete cata-
cholamines, and are innervated by the sympathetics. These
tumors derive from the chromaffin cells of the adrenal
gland. Ten to 20% of sympathetic paragangliomas (PGLs)
are found in extra-adrenal paraganglioma locations such as
the organ of Zuckerkandl, the sympathetic plexus of the
urinary bladder, the kidneys, the heart, and the sympathetic
ganglia in the mediastinum.1 Head and neck paraganglio-
mas (HNPGLs) are most often innervated by the parasym-
pathetic system, they rarely have active secretory function,
and are commonly located at the carotid bifurcation pre-
senting as carotid body tumors.2 While the preponderance
of paragangliomas occur in a sporadic setting, up to 35% of
cases may have a genetic predisposition.3
Germline mutations affecting genes encoding for the
subunits of succinate dehydrogenase, mitochondrial com-
plex II of the electron transport chain, are responsible for
the PGL syndrome.1,2,4 Succinate dehydrogenase consists
of subunits A, B, C, and D (SDHA, SDHB, SDHC, and
SDHD). The PGL syndrome is further subclassified into
four entities based on the specific subunit that has been
affected by themutation (Table). The SDHDgene is found
on chromosome 11q23 and is responsible for PGL-1 syn-
drome. Patients with PGL-1 are more likely to have multi-
ple primary tumors compared with patients with other
subtypes of the PGL syndrome.3 Chromosome 11q13 is
thought to be responsible for the PGL-2 syndrome, al-
though the specific gene mutation and phenotype have yet
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doi:10.1016/j.jvs.2010.09.064o be defined. The PGL-4 syndrome is characterized by a
utation of the SDHB gene on chromosome 1p36. These
umors are most likely to be single rather thanmultiple, and
utations of the SDHB gene are more likely to be associ-
ted with malignancy than the other subtypes.3 Mutations
n the SDHA gene are associated with Leigh syndrome,
hich is not associated with the above-mentioned PGL
umor syndromes.
Mutations of the SDHC gene at chromosome 1q21
ead to the PGL-3 syndrome.Mutations of the SDHCgene
appen less commonly than those of the SDHC and SDHB
enes. Phenotypically, while mutations of the SDHB and
DHD gene can present with PGLs at various locations
rom the middle ear and skull base to the pelvic floor
abdominal, thoracic, cervical, mediastinal), mutations in
he SDHC gene present almost exclusively with HNPGLs.
umors are most likely to be single and benign in nature.3,5
bdominal PGLs are rare and a PC with an SDHC muta-
ion has only been reported twice in the literature.6,7 Brief
ention of 2 patients presenting with a solitary functional
horacic PGL has been made in a large prospective series of
atients with PGLs.8 To our knowledge, there has yet to be
patient with the SDHCmutation whomanifests nonfunc-
ional synchronous HNPGL and thoracic PGL.
ASE REPORT
An otherwise healthy 32-year-old man, with no significant
edical or surgical history, presented to our hospital with a 6-week
istory of left neck pain and swelling. A computed tomography
CT) scan of the neck demonstrated a 4-centimeter mass of the
arotid bifurcation, consistent with a carotid paraganglioma. A
tandard preoperative chest radiograph was done revealing a soft
issue mass within the aortopulmonary window. Subsequent CT
ngiography demonstrated a 3-centimeter, highly vascularized,
oft tissue mass below the aortic arch and above the pulmonary
rtery (Fig 1). Preoperative planning included a collection of
lasma metanephrines and normetanephrines, both of which were
ormal, ruling out a functional tumor.
The patient underwent successful resection of his carotid body
umor. Given the highly vascularized nature of the thoracic mass,
fter recovering from his initial operation, he was taken for an
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March 2011806 Vandy et alangiography. The tumor was seen to be primarily fed by a tortuous
branch off the internal mammary artery, which was embolized
before the resection. After embolization, the patient was taken the
next day for a left thoracotomy and the tumor was removed
successfully from its location in the aortopulmonary window (Fig
2). The postoperative course was uncomplicated and the patient
went home on the third day.
During his hospitalization, the patient was tested for mutation
of the SDHA and SDHB genes, both of which were normal. A CT
scan of the abdomen and pelvis did not reveal any further tumors.
He was referred for genetic counseling at which point genetic
analysis of the SDHC and SDHD genes was performed. He was
found to be heterozygous for a nonsense mutation, c.43CT (p.
Arg15X), in the SDHC gene. Further genetic analysis revealed an
identical mutation in the patient’s mother and in the patient’s
oldest son. A magnetic resonance imaging scan of the patient’s
mother and son did not reveal a PGL.
DISCUSSION
The prevalence of SDHC mutations in HNPGLs is
4%.5 Classically, SDHC mutations present almost exclu-
Table. Summary of the paraganglioma syndromes
Syndrome Gene mutation Chromosome
PGL-1 SDHD 11q23
PGL-2 ? 11q13
PGL-3 SDHC 1q23
PGL-4 SDHB 1p36
Leigh syndrome SDHA 5p15
HNPGL, Head and neck paraganglioma; N/A, not applicable; PGL, p
dehydrogenase subunit B; SDHC, succinate dehydrogenase subunit C; SDH
Fig 1. Computed tomography (CT) 3-dimensional reconstruc-
tion of a tumor at the aortopulmonary window (large arrow), with
tortuous blood supply (small arrow).sively as HNPGLs. Peczkowska et al6 and Mannelli et al7 dave described the only two known cases of PGL-3 syn-
rome presenting with PC. Pasini and Stratakis3 report on
he only three cases of this syndrome with abdominal PGL,
wo of which also were found to have the Carney-Stratakis
yad, a PGL presenting with a concomitant gastrointestinal
tromal tumor.9 The c.43CT mutation in our patient has
nly been described one other time.10 Our case represents
hree generations in the first family with the c.43CT
ermline mutation and the first time the PGL-3 syndrome
as presented with multiple PGLs of thoracic and carotid
ody origin.
Determination of malignancy in paragangliomas can be
ifficult given the similar histologic appearance of both
alignant and benign tumors. Both benign and malignant
umors demonstrate an increased mitotic rate and capsular
nvasion, so the only true measure of malignancy is meta-
tatic disease to lymph nodes or non-neuroendocrine tis-
ue.11 The occurrence of malignant disease in PGL-3 syn-
rome is rare, with an incidence between 0% to 3%.3,5 In
he case at hand, regional lymph nodes from the cervical
Common phenotype Malignant
HNPGL, adrenal PGL Rare
HNPGL Rare
HNPGL Rare
Extra-adrenal PGL Common
Subacute necrotizing encephalomyelopathy N/A
glioma; SDHA, succinate dehydrogenase subunit A; SDHB, succinate
ccinate dehydrogenase subunit D.
Fig 2. Tumor removed at the time of operation.araganissection were negative for metastatic disease. Thus, we
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mary tumors, one of the carotid body and one in the
aortopulmonary window.
Large studies have dispelled the classic teaching that
10% of PCs are hereditary. An estimated 25% of all PCs or
other functional PGLs, and up to 35% of HNPGLs, have a
familial origin.3,12 However, in patients with PC or func-
tional PGLs who are prescreened using genetic counseling
and clinical assessment, this number approaches 60%.12
Conversely, presumed sporadic cases which fail to demon-
strate a familial origin after clinical screening still demon-
strate the presence of a mutation 10% to 15% of the time.12
Although mutations in SDHC are less common than mu-
tations in SDHB and SDHB, the phenotypic presentation
of an SDHC mutation, once thought to be exclusively
HNPGL, is expanding to include PC and abdominal and
thoracic PGLs. A broader approach to genetic analysis in
patients with multiple PGLs and/or PC may be warranted.
The uncertain natural history of the PGL syndromes
mandates lifelong follow-up. The incidence of metachro-
nous tumors after resection is unknown. Furthermore,
unaffected carriers of the SDHC mutation must be
screened routinely for early development of a PGL and PC
given the literature’s support of PCs arising in mutations of
the SDHC gene. We plan to follow our patient and his
affected family members with yearly physical examinations
and annual plasma metanephrine and normetanephrine
testing. Additionally, imaging with serial magnetic reso-
nance imaging scans of the head and neck, chest, and
abdomen will be done every 2 years.
CONCLUSION
Germline mutations responsible for the PGL syn-
dromes may be more common than once suspected. The
phenotype of SDHC mutations has grown to include not
only HNPGLs but also functioning and nonfunctioning
thoracic and abdominal PGLs. Consideration of genetic
screening for all SDH mutations should be given to pa-
tients presenting with multiple PGLs. SEFERENCES
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